Publisher： Bentham Science Publishers
E-ISSN： 2212-3938|6|3|151-163
ISSN： 1574-8847
Source： Current Clinical Pharmacology, Vol.6, Iss.3, 2011-08, pp. : 151-163
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cripto as a target for cancer immunotherapy
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. :
Access to resources
Recommend
Immunotherapy for Prostate Cancer
Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. :
Cancer Immunotherapy Companies
Pharmaceutical Innovation, Vol. 11, Iss. 3, 2002-04 ,pp. :
Lentiviruses in cancer immunotherapy
By Breckpot Karine Thielemans K
Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. :
Cancer immunotherapy shrivels tumours
Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. :